HBV-Derived Synthetic Long Peptide Can Boost CD4(+) and CD8(+) T-Cell Responses in Chronic HBV Patients Ex Vivo

Yingying Dou, Nadine Montfoort, Aniek Bosch, Rob de Man, GG Zom, WJ Krebber, CJM Melief, Sonja Buschow, Andrea Woltman

Research output: Contribution to journalArticleAcademicpeer-review

15 Citations (Scopus)
21 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)827-839
Number of pages13
JournalJournal of Infectious Diseases
Issue number5
Publication statusPublished - 2018

Research programs

  • EMC MM-04-20-02-A

Cite this